Corticosterone-Induced Lipogenesis Activation and Lipophagy Inhibition in Chicken Liver Are Alleviated by Maternal Betaine Supplementation

J Nutr. 2018 Mar 1;148(3):316-325. doi: 10.1093/jn/nxx073.

Abstract

Background: We have shown previously that in ovo betaine injection can prevent nonalcoholic fatty liver induced by glucocorticoid exposure in chickens; yet it remains unknown whether feeding betaine to laying hens may exert similar effects in their progeny.

Objective: In this study, we fed laying hens a betaine-supplemented diet, and the progeny were later exposed chronically to corticosterone (CORT) to test hepatoprotective effects and further elucidate underlying mechanisms.

Methods: Rugao yellow-feathered laying hens (n = 120) were fed a basal (control, C) diet or a 0.5% betaine-supplemented (B) diet for 28 d before their eggs were collected for incubation. At 49 d of age, male chickens selected from each group were daily injected subcutaneously with solvent (15% ethanol; vehicle, VEH) or CORT (4.0 mg/kg body mass) for 7 d to establish a fatty liver model. Chickens in the 4 groups (C-VEH, C-CORT, B-VEH, and B-CORT) were killed at day 57. Plasma and hepatic triglyceride (TG) concentrations, as well as the hepatic expression of genes involved in lipogenesis and lipophagy, were determined.

Results: CORT induced a 1.6-fold increase in the plasma TG concentration (P < 0.05) and a 1.8-fold increment in the hepatic TG concentration (P < 0.05), associated with activation of lipogenic genes (70-780%). In contrast, lipophagy and mitochondrial β-oxidation genes were inhibited by 30-60% (P < 0.05) in CORT-treated chickens. These CORT-induced changes were completely normalized by maternal betaine supplementation or were partially normalized to intermediate values that were significantly different from those in the C-VEH and C-CORT groups. These effects were accompanied by modifications in CpG methylation and glucocorticoid receptor binding to the promoters of major lipogenic and lipophagic genes (P < 0.05).

Conclusions: These results indicate that maternal betaine supplementation protects male juvenile chickens from CORT-induced TG accumulation in the liver via epigenetic modulation of lipogenic and lipophagic genes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Betaine / pharmacology
  • Betaine / therapeutic use*
  • Chickens
  • Corticosterone / adverse effects*
  • Corticosterone / metabolism
  • DNA Methylation / drug effects
  • Dietary Supplements*
  • Disease Models, Animal
  • Epigenesis, Genetic
  • Fatty Liver / etiology
  • Fatty Liver / metabolism
  • Fatty Liver / prevention & control*
  • Female
  • Lipid Metabolism / drug effects
  • Lipid Metabolism / genetics
  • Lipogenesis / drug effects
  • Lipogenesis / genetics
  • Liver / drug effects*
  • Liver / metabolism
  • Male
  • Mitochondria
  • Mitochondrial Proteins / genetics
  • Pregnancy
  • Prenatal Nutritional Physiological Phenomena*
  • Promoter Regions, Genetic
  • Receptors, Glucocorticoid / metabolism
  • Triglycerides / metabolism*

Substances

  • Mitochondrial Proteins
  • Receptors, Glucocorticoid
  • Triglycerides
  • Betaine
  • Corticosterone